Debridement composition
The disclosed technology relates to a wound dressing comprising an absorbent layer impregnated or coated with a composition comprising a chelating agent, an amphoteric surfactant, and an anionic surfactant. The invention further relates to methods and uses of the wound dressing.
1 . A wound dressing or debridement tool comprising an absorbent layer impregnated or coated with a composition comprising
a chelating agent present at 0.01 to 1 wt. % and comprises a salt of ethylenediaminetetra-acetic acid (EDTA),
an amphoteric surfactant present at 0.01 to 1.5 wt. % and comprises sodium cocoamphoacetate, and
an anionic surfactant present at 0.05 to 1.5 wt. % and comprises sodium oleate.
2 . The wound dressing or debridement tool of claim 1 , wherein the anionic surfactant is present at 0.1 to 1 wt % or 0.1 to 0.5 wt %.
3 . The wound dressing or debridement tool of claim 1 , wherein the anionic surfactant further comprises an anionic surfactant chosen from a fatty acid or fatty acid salt, a sulphate, a sulphosuccinate, a sarcosine, a sarcosinate, an isethionate, a glutamate, or a taurate.
4 . The wound dressing or debridement tool of claim 1 , wherein the amphoteric surfactant is present at 0.02 to 0.8 wt % or 0.05 to 0.5 wt %.
5 . The wound dressing or debridement tool of claim 1 , wherein the amphoteric surfactant further comprises an amphoteric surfactant chosen from an hydrocarbyl-amphoacetate, alkenyl-amphoacetate, hydrocarbyl-amphodiacetate, alkenyl-amphodiacetate, hydrocarbylampho-propionate, hydrocarbylampho-dipropionate, or hydrocarbylamphohydroxypropyl sultaine, wherein the hydrocarbyl and alkenyl groups contain 6 to 24, or 8 to 24 carbon atoms.
6 . The wound dressing or debridement tool of claim 1 , wherein the chelating agent is present at 0.1 to 0.75 wt % or 0.1 to 0.5 wt %.
7 . The wound dressing or debridement tool of claim 1 , wherein the chelating agent further comprises a chelating agent chosen from a hydroxy-carboxylic acid ester or amide acid, or salts thereof, an oxalate, or a phosphate.
8 . The wound dressing or debridement tool of claim 1 , wherein the composition is impregnated or coated in the wound dressing and comprises:
the chelating agent is present at 0.1 to 0.75 wt %,
the anionic surfactant is present at or 0.1 to 1 wt %, or
the amphoteric surfactant is present at or 0.02 to 0.8 wt %.
9 . The wound dressing or debridement tool of claim 1 , wherein the composition is impregnated or coated in the wound dressing and comprises:
the chelating agent is present at 0.1 to 0.5 wt %,
the anionic surfactant is present at 0.1 to 0.5 wt %
the amphoteric surfactant is present at or 0.05 to 0.5 wt %.
10 . The wound dressing or debridement tool of claim 1 , wherein the composition impregnated or coated in the wound dressing or debridement tool comprises:
the chelating agent is present at 0.1 to 0.5 wt % (or 0.15 to 1.5 gm −2 ),
the anionic surfactant is present at 0.1 to 0.5 wt % (or 0.15 to 1.5 gm −2 ), and
the amphoteric surfactant is present at or 0.05 to 0.4 wt % (or 0.075 to 0.6 gm −2 ).
11 . The wound dressing or debridement tool of claim 1 , wherein the composition impregnated or coated in the wound dressing or debridement tool further comprises:
an amphoteric surfactant chosen from an hydrocarbyl-amphoacetate, alkenyl-amphoacetate, hydrocarbyl-amphoacetate, alkenyl-amphoacetate, hydrocarbylampho-propionate, hydrocarbylampho-dipropionate, or hydrocarbylamphohydroxypropyl sultaine, wherein the hydrocarbyl groups contain 6 to 24, or 8 to 24 carbon atoms;
an anionic surfactant chosen from a fatty acid or fatty acid salt, sulphate, a sulphosuccinate, a sarcosine, a sarcosinate, an isethionate, taurate, and a glutamate; and
a chelating agent chosen from a hydroxy-carboxylic acid ester or amide acid, or salts thereof (for example a citrate, tartrate, tartramide, or tartrimide, gluconic acid, a gluconate, a lactate, lactic acid, glycolic acid, or glycolate), an oxalate, or a phosphate.
12 . The wound dressing or debridement tool of claim 1 , wherein the composition impregnated or coated in the wound dressing further comprises:
an amphoteric surfactant chosen from an hydrocarbyl-amphoacetate, alkenyl-amphoacetate, hydrocarbyl-amphoacetate, alkenyl-amphoacetate, hydrocarbylampho-propionate, hydrocarbylampho-dipropionate, or hydrocarbylamphohydroxypropyl sultaine, wherein the hydrocarbyl groups contain 6 to 24, or 8 to 24 carbon atoms;
an anionic surfactant chosen from a fatty acid or fatty acid salt, a glutamate, a sulphosuccinate, a sarcosine, or a sarcosinate; and
a chelating agent chosen from an oxalate, a citrate, or a phosphate.
13 . The wound dressing or debridement tool of claim 1 , wherein the composition impregnated or coated in the wound dressing further comprises: a nonionic surfactant.
14 . The wound dressing of claim 13 , wherein the nonionic surfactant is present at 0.01 to 0.7 wt % (or 0.015 to 1.05 gm −2 ), or 0.05 to 0.5 wt % (or 0.075 to 0.75 gm −2 ), or 0.1 to 0.3 wt % (or 0.15 to 0.45 gm −2 ).
15 . The wound dressing or debridement tool of claim 1 , wherein the composition impregnated or coated in the wound dressing or debridement tool comprises:
the chelating agent is present at 0.01 to 1 wt % (or 0.015 to 1.5 gm −2 ),
the anionic surfactant is present at 0.05 to 1.5 wt % (or 0.075 to 2.25 gm −2 ),
the amphoteric surfactant is present at 0.01 to 1.5 wt % (or 0.015 to 2.25 gm −2 ), and
the nonionic surfactant is present at 0.01 to 0.7 wt % (or 0.015 to 1.05 gm −2 ).
16 . The wound dressing or debridement tool of claim 13 , wherein the nonionic surfactant is chosen from polyoxyethylene fatty acid esters, polyoxyethylene glycol fatty acid esters, sucrose fatty acid esters, poly-oxyethylene hydrogen carbonate castor oils, and polyoxyethylene alkyl ethers.
17 . The wound dressing or debridement tool of claim 1 , wherein the absorbent layer impregnated or coated with the composition comprises at least one layer composed of a foam, absorbent, or a gel-forming fibre.
18 . The wound dressing or debridement tool of claim 1 , wherein the wound dressing absorbent layer is a gel-forming fibre.
19 . The wound dressing or debridement tool of claim 1 , wherein the wound dressing absorbent layer is a gel-forming fibre, and wherein the fibre is chemically modified carboxymethylcellulose fibres.
20 . A composition comprising a chelating agent present at 0.01 to 1 wt. % and comprises a salt of ethylenediaminetetra-acetic acid (EDTA), an amphoteric surfactant present at 0.01 to 1.5 wt. % and comprises sodium cocoamphoacetate, and an anionic surfactant present at 0.05 to 1.5 wt. % and comprises sodium oleate for use in the treatment of a wound selected from the group consisting of a chronic wound, acute wound, burn, a wound comprising a bacterial biofilm, and a wound comprising slough.